The Association for Molecular Pathology (AMP), the premier global, non-profit organization serving molecular testing professionals announced that it has added a late-breaking session addressing laboratory developed procedures (LDPs) oversight and regulation to its 2014 Annual Meeting program (www.amp.org/2014). The decision to add this important session stems from the recently published draft guidance, Framework for Oversight of Laboratory Developed Tests, issued by the U.S. Food and Drug Administration (FDA) on October 3, 2014.
Help employers find you! Check out all the jobs and post your resume.
